Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma (original) (raw)
References
Andreasen PA, Riccio A, Welinder KG, Douglas R, Sartorio R, Nielsen LS, Oppenheimer C, Blasi F, Danø K (1986a) Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett 209:213–218 Google Scholar
Andreasen PA, Christensen TH, Huang J-Y, Nielsen LS, Wilson EL, Danø K (1986b) Hormonal regulation of extracellular plasminogen activators and Mr 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies. Mol Cell Endocrinol 45:137–147 Google Scholar
Andreasen PA, Pyke C, Riccio A, Kristensen P, Nielsen LS, Lund LR, Blasi F, Danø K (1987) Plasminogen activator inhibitor type-1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells. Mol Cell Biol 7:3021–3025 Google Scholar
Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68:1–19 Google Scholar
Appella E, Robinson EA, Ullrich S-J, Stoppelli MP, Corti A, Cassani G, Blasi F (1987) The receptor-binding sequence of urokinase. J Biol Chem 262:4437–4440 Google Scholar
Blasi F, Vassalli J-D, Danø K (1987) Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J Cell Biol 104:801–804 Google Scholar
Collen D (1986) Tissue-type plasminogen activator (t-PA) and singlechain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy. Prog Hemostasis Thromb 8:1–18 Google Scholar
Danø K, Reich E (1979) Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction. Biochim Biophys Acta 566:138–151 Google Scholar
Danø K, Møller V, Ossowski L, Nielsen LS (1980a) Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus. Biochim Biophys Acta 613:542–555 Google Scholar
Danø K, Nielsen LS, Møller V, Engelhart M (1980b) Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme. Biochim Biophys Acta 630:146–151 Google Scholar
Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139–266 Google Scholar
Danø K, Behrendt N, Lund LR, Rønne E, Pöllänen J, Salonen E-M, Stephens RW, Tapiovaara H, Vaheri A (1989) Cell surface plasminogen activation. In: Schirrmacher V, Schwartz-Albeiz R (eds) Cancer metastasis: molecular and cellular biology, host immune responses and perspectives for treatment. Springer, Berlin Heidelberg New York, pp 83–90 Google Scholar
Ellis V, Scully MF, Kakkar VV (1989) Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 263:2185–2188 Google Scholar
Erickson LA, Lawrence DA, Loskutoff DJ (1984) Reverse fibrin autoradiography: a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem 137:454–463 Google Scholar
Erickson LA, Hekman CM, Loskutoff DJ (1985) The primary plasminogen activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc Natl Acad Sci USA 82:8710–8714 Google Scholar
Georg B, Helseth E, Lund LR, Skandsen T, Riccio A, Danø K, Unsgaard G, Andreasen PA (1989) Tumor necrosis factor-α regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines. Mol Cell Endocrinol 61:87–96 Google Scholar
Ginsburg D, Zeheb R, Yang YA, Rafferty UM, Andreasen PA, Nielsen LS, Danø K, Lebo RV, Gelehrter TD (1986) cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 78:1673–1680 Google Scholar
Granelli-Piperno A, Reich E (1978) A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 148:223–234 Google Scholar
Grøndahl-Hansen J, Ralfkiar E, Nielsen LS, Kristensen P, Frentz G, Danø K (1987) Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88:28–32 Google Scholar
Hebert CA, Baker JB (1988) Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J Cell Biol 106:1241–1247 Google Scholar
Kristensen P, Larsson L-I, Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Danø K (1984) Human endothelial cells contain one type of plasminogen activator. FEBS Lett 168:33–37 Google Scholar
Kristensen P, Nielsen LS, Grøndahl-Hansen J, Andresen PB, Larsson L-I, Danø K (1985) Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland. J Cell Biol 101:305–311 Google Scholar
Kristensen P, Hougaard DM, Nielsen LS, Danø K (1986) Tissue-type plasminogen activator in rat medulla. Histochemistry 85:431–436 Google Scholar
Kristensen P, Nielsen JH, Larsson L-I, Danø K (1987) Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus. Endocrinology 121:2238–2244 Google Scholar
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685 Google Scholar
Larsson L-I, Skriver L, Nielsen LS, Grøndahl-Hansen J, Kristensen P, Danø K (1984) Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98:894–903 Google Scholar
Leary JJ, Brigati DJ, Ward DC (1983) Rapid and sensitive colorimetric method for visualizing biotinlabeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bioblots. Proc Natl Acad Sci USA 80:4045–4049 Google Scholar
Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Danø K (1987) Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281–1286 Google Scholar
Mayer M, Lund LR, Riccio A, Skouv J, Nielsen LS, Stacey SN, Danø K, Andreasen PA (1988) Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells. J Biol Chem 263:15688–15693 Google Scholar
McGradey J (1970) A tetrazolium method for non-specific alkaline phosphatase. Histochemie 23:180–184 Google Scholar
Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47:487–498 Google Scholar
Nielsen LS, Andreasen PA, Grøndahl-Hansen J, Huang J-Y, Kristensen P, Danø K (1986a) Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells — inhibitor neutralization and one-step affinity purification. Thromb Haemost 55:206–212 Google Scholar
Nielsen LS, Andreasen PA, Grøndahl-Hansen J, Skriver L, Danø K (1986b) Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass. FEBS Lett 196:269–273 Google Scholar
Nowel PC (1986) The clonal evolution of tumor cell populations. Science 194:23–28 Google Scholar
Ny T, Sawdey M, Lawrence D, Millan JJ, Loskutoff DJ (1986) Cloning and sequence of a cDNA coding for the human betamigrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83:6776–6780 Google Scholar
Ossowski L, Reich E (1983) Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell 33:323–333 Google Scholar
Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij VL, van Zonneveld A-J, van Mourik JA (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the serpin gene family. EMBO J 5:2539–2544 Google Scholar
Philips M, Juul A-G, Thorsen S, Selmer J, Zeuthen J (1986) Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta. Thromb Haemost 55:213–217 Google Scholar
Pöllänen J, Saksela O, Salonen E-M, Andreasen P, Nielsen LS, Danø K, Vaheri A (1987) Distinct localizations of urokinase-type plasminogen activator and its type-1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085–1096 Google Scholar
Pöllänen J, Hedman K, Nielsen LS, Danø K, Vaheri A (1988) Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol 106:87–95 Google Scholar
Quigley JP, Goldfarb RH, Scheiner C, O'Donnell-Tormey J, Yeo TK (1980) Plasminogen activator and the membrane of transformed cells. In: Hynes RO, Fox CF (eds) Tumor cell surfaces and malignancy, pp 773–796
Riccio A, Lund LR, Sartorio R, Lania A, Andreasen PA, Danø K, Blasi F (1988) The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. Nucleic Acid Res 16:2805–2824 Google Scholar
Saksela O, Rifkin DB (1988) Cell-assocuated plasminogen activation: Regulation and physiological functions. Ann Rev Cell Biol 4:93–126 Google Scholar
Skriver L, Larsson L-I, Kielberg V, Nielsen LS, Andresen PB, Kristensen P, Danø K (1984) Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol 99:752–757 Google Scholar
Stephens RW, Pöllanen J, Tapiovaara H, Leung K-C, Sim P-S, Salonen E-M, Rønne E, Behrendt N, Danø K, Vaheri A (1989) Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 108:1987–1995 Google Scholar
Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Associan RK (1985) Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 82:4939–4943 Google Scholar
Sugiura K, Stock CC (1955) Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors. Cancer Res 15:38–51 Google Scholar
Vassalli J-D, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86–92 Google Scholar
Vuento M, Vaheri A (1979) Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 183:331–337 Google Scholar